Indeed, in individuals with obesity and T2D, chronic low-grade inflammation, characterized by elevated IL-6 levels in various tissues, can contribute to reduced insulin sensitivity and impaired glucose metabolism [90]. The gene discussed is INS; the disease is Obesity.